Product details
Catalog number BNUM2400-50
Price for BNUM2400-50
Size / count 1x 50 µL
Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuro-epithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid / rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue (gliosis) .Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
The catalog number for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), 1mg/mL is BNUM2400-50.
OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), 1mg/mL is available in the following size(s): 1x 50 µL.
OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), 1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.
OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), 1mg/mL is manufactured by Biotium.
Estimated delivery time for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), 1mg/mL is approximately 15 business day(s), depending on your location.
The safety data sheet for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), 1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd029c061270361e102364/msds/bnum2400-50.pdf.
Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms
Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.
Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.
Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.